UNSPSC 51151640: Fenpiverinium

This classification denotes an antimuscarinic agent with the molecular formula C22H29N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KP2L8LC73B. European Medicines Agency schedules fenpiverinium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02124MIG. FENPIVERINIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, FENPIVERINIUM remains the US FDA Preferred Term for this commodity.

Fenpiverinium bears US NLM identifiers UMLS ID C0060190 and NCI Concept Code C87638. SMILES: C[N+]1(CCCCC1)CCC(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N.

UNSPSC 51151640 Fenpiverinium is a Commodity code that captures pharmaceutical products, though recent state and local solicitations under this code reflect a narrow and specialized procurement pattern centered on emergency-response pharmaceuticals and harm-reduction products rather than the code's nominal scope. Seminole County, Florida posted an IFB seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually in support of community health initiatives, indicating that the code in practice encompasses opioid-reversal medications and drug-disposal systems rather than fenpiverinium specifically. The issuing body is a county government, and the procurement requires quarterly deliveries with all shipping included in pricing, electronic bid submission, E-Verify compliance, and a fixed-fee structure with an initial two-year term and optional one-year renewal.

The geographic spread is limited to Florida based on recent activity, with Seminole County representing the sole identified state or local buyer in the recent-opportunities record. The IFB (Solicitation Number IFB60459723LAS) was posted June 30, 2026, with a response deadline of July 26, 2023—a date that appears inconsistent with the posting date and may indicate a data-entry error in the source. Bidders must comply with drug-free workplace certification, federal regulations tied to potential FEMA funding (Clean Air Act and Federal Water Pollution Control Act), and standard insurance requirements including workers' compensation and commercial general liability. The procurement includes a three-month probationary period permitting termination by the county with or without cause, and no explicit set-aside designations for disadvantaged enterprises are stated.